You are here : Home / All Sectors / Healthcare / Hospital & Healthcare Services / DR LAL PATHLABS

DR LAL PATHLABS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -2.4% , 1M : -11.9%,1Y : 73.2%
www.lalpathlabs.com
BOM : 539524     NSE : LALPATHLAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Oct 18,2021
Price(EOD): Rs. 3,607.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
DR LAL PATHLABS -2.4% -11.9% 73.2%
APOLLO HOSPITALS ENTERPRISE -1.1% -11.2% 92%
MAX HEALTHCARE INSTITUTE -0.8% -14.9% 210.8%
FORTIS HEALTHCARE -2% -3.8% 101.5%
METROPOLIS HEALTHCARE -4.8% -15.5% 35.5%
ASTER DM HEALTHCARE -4.1% -10.1% 55.3%
NARAYANA HRUDAYALAYA 5.8% -2.3% 41.5%
KRISHNA INSTITUTE OF MEDICAL SCIENCES -0.7% -7.9% NA
THYROCARE TECHNOLOGIES 0.6% -8.7% 3.8%


FUNDAMENTAL ANALYSIS OF DR LAL PATHLABS

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than DR LAL PATHLABS Plus/Pro


VALUATION OF DR LAL PATHLABS

 
Valuation Score
[As on : Oct 18,2021 ]

Ratio Consolidated
P/E
P/B
P/S
103.11
P/E Calculated based on EPS of 34.99
[ Mar2021 - Consolidated Results ]

24.95
P/B Calculated based on Book Value of 144.61
[ Mar2021 - Consolidated Results ]

15.64
P/S Calculated based on Revenues of 1921.9 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than DR LAL PATHLABS Plus/Pro


FAIR VALUE OF DR LAL PATHLABS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
99%
57%
57%

SHARE PRICE MOMENTUM OF DR LAL PATHLABS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0
0
0
-
0
0
0
-
[Last Annual Data : Mar2021]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
40.74%
54.92%
61.82%
57.11%
128.05%
291.3%
370.6%
370.78%
QtrlyTrend
8
Latest Qtr: Jun2021

DR LAL PATHLABS related INDICES

BSE Indices1W1M1Y
S&P BSE 150 MIDCAP 3.5% 7.2% 88.2%
S&P BSE 400 MIDSMALLCAP 3.1% 7.2% 90.9%
S&P BSE 200 3.1% 5% 59.2%
S&P BSE 250 LARGEMIDCAP 3% 5% 59.9%
S&P BSE 500 3% 5.2% 62%
S&P BSE ALLCAP 3% 5.3% 63.3%
S&P BSE MIDSMALLCAP 2.8% 6.4% 91.4%
S&P BSE SMALLCAP SELECT INDEX 2.3% 6.4% 92.6%
S&P BSE SMALL CAP 2% 6.3% 100.5%
S&P BSE HEALTHCARE -0.3% -2.3% 29.7%
NSE Indices1W1M1Y
NIFTY FREE MIDCAP 100 4% 8.6% 91.3%
NIFTY MIDCAP150 3.2% 7.4% 87%
NIFTY 200 3.1% 5.1% 59.1%
NIFTY 500 3% 5.2% 61.8%
NIFTY MID SMALL400 2.9% 7.3% 90.4%
NIFTY LARGE MIDCAP 250 2.7% 5.6% 68.8%
NIFTY500 MULTICAP 50:25:25 2.6% 5.5% NA
NIFTY HEALTHCARE 1.3% -1.3% NA
NIFTY MIDCAP150 QUALITY 50 1% 4% NA

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


Is DR LAL PATHLABS good for long term investment?

As on 18-Oct-2021, the Fundamentals of DR LAL PATHLABS look Strong and hence it may be good for long term investment! See Financial Performance of DR LAL PATHLABS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DR LAL PATHLABS UnderValued or OverValued?

As on 18-Oct-2021, DR LAL PATHLABS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of DR LAL PATHLABS ?

As on 18-Oct-2021, the Intrinsic Value of DR LAL PATHLABS is Rs. 2,294.93 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,810.29
Fair Value [Median EV / Sales Model] : Rs. 2,296.70
Fair Value [Median Price / Sales Model] : Rs. 2,294.93
Median Fair Value of DR LAL PATHLABS : Rs. 2,294.93

Is DR LAL PATHLABS trading at a Premium or Discount?

As on 18-Oct-2021, DR LAL PATHLABS is trading at a Premium of 57% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of DR LAL PATHLABS ?

Check out Annual Financials of Industry Peers
Share Price & Financials of APOLLO HOSPITALS ENTERPRISE LTD | BOM: 508869 | NSE: APOLLOHOSP
Share Price & Financials of MAX HEALTHCARE INSTITUTE LTD | BOM: 543220 | NSE: MAXHEALTH
Share Price & Financials of FORTIS HEALTHCARE LTD | BOM: 532843 | NSE: FORTIS
Share Price & Financials of METROPOLIS HEALTHCARE LTD | BOM: 542650 | NSE: METROPOLIS
Check out Quarterly Results of Industry Peers
Quarterly Results of APOLLO HOSPITALS ENTERPRISE LTD
Quarterly Results of MAX HEALTHCARE INSTITUTE LTD
Quarterly Results of FORTIS HEALTHCARE LTD
Quarterly Results of METROPOLIS HEALTHCARE LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs DR LAL PATHLABS LTD
FORTIS HEALTHCARE LTD vs METROPOLIS HEALTHCARE LTD vs ASTER DM HEALTHCARE LTD
NARAYANA HRUDAYALAYA LTD vs KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD vs THYROCARE TECHNOLOGIES LTD
SHALBY LTD vs KOVAI MEDICAL CENTER & HOSPITAL LTD vs KMC SPECIALITY HOSPITALS (INDIA) LTD
INDRAPRASTHA MEDICAL CORPORATION LTD vs KAYA LTD vs ARTEMIS MEDICARE SERVICES LTD
Browse Market Cap of Industry Peers
Market Cap of APOLLO HOSPITALS ENTERPRISE LTD
Market Cap of MAX HEALTHCARE INSTITUTE LTD
Market Cap of FORTIS HEALTHCARE LTD
Market Cap of METROPOLIS HEALTHCARE LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z